BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17172841)

  • 1. Cell cycle synchronization at the G2/M phase border by reversible inhibition of CDK1.
    Vassilev LT
    Cell Cycle; 2006 Nov; 5(22):2555-6. PubMed ID: 17172841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity.
    Sunada S; Saito H; Zhang D; Xu Z; Miki Y
    Biochem Biophys Res Commun; 2021 Apr; 550():56-61. PubMed ID: 33684621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1.
    Vassilev LT; Tovar C; Chen S; Knezevic D; Zhao X; Sun H; Heimbrook DC; Chen L
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10660-5. PubMed ID: 16818887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific inhibitor of CDK1, RO-3306, reversibly arrests meiosis during in vitro maturation of porcine oocytes.
    Jang WI; Lin ZL; Lee SH; Namgoong S; Kim NH
    Anim Reprod Sci; 2014 Jan; 144(3-4):102-8. PubMed ID: 24374180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
    Van Dolah FM; Ramsdell JS
    J Cell Physiol; 1996 Jan; 166(1):49-56. PubMed ID: 8557775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jumping the nuclear envelop barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306.
    Zhou X; Liu X; Zhao B; Liu X; Zhu D; Qiu N; Zhou Q; Piao Y; Zhou Z; Tang J; Shen Y
    J Control Release; 2016 Jul; 234():90-7. PubMed ID: 27212103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.
    Prevo R; Pirovano G; Puliyadi R; Herbert KJ; Rodriguez-Berriguete G; O'Docherty A; Greaves W; McKenna WG; Higgins GS
    Cell Cycle; 2018; 17(12):1513-1523. PubMed ID: 30045664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronization of HeLa Cells.
    Ma HT; Poon RY
    Methods Mol Biol; 2017; 1524():189-201. PubMed ID: 27815904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events.
    McCloy RA; Rogers S; Caldon CE; Lorca T; Castro A; Burgess A
    Cell Cycle; 2014; 13(9):1400-12. PubMed ID: 24626186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cdk1 by alsterpaullone and thioflavopiridol correlates with increased transit time from mid G2 through prophase.
    Soni DV; Jacobberger JW
    Cell Cycle; 2004 Mar; 3(3):349-57. PubMed ID: 14726692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition.
    Barboule N; Lafon C; Chadebech P; Vidal S; Valette A
    FEBS Lett; 1999 Feb; 444(1):32-7. PubMed ID: 10037143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RO-3306 prevents postovulatory aging-mediated spontaneous exit from M-II arrest in rat eggs cultured in vitro.
    Prasad S; Koch B; Chaube SK
    Biomed Pharmacother; 2016 Mar; 78():216-225. PubMed ID: 26898445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of eIF4GII and 4E-BP1 in response to nocodazole treatment: a reappraisal of translation initiation during mitosis.
    Coldwell MJ; Cowan JL; Vlasak M; Mead A; Willett M; Perry LS; Morley SJ
    Cell Cycle; 2013 Dec; 12(23):3615-28. PubMed ID: 24091728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lethal response to Cdk1 inhibition depends on sister chromatid alignment errors generated by KIF4 and isoform 1 of PRC1.
    Voets E; Marsman J; Demmers J; Beijersbergen R; Wolthuis R
    Sci Rep; 2015 Oct; 5():14798. PubMed ID: 26423135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of timing of embryonic M-phase entry and exit is differentially sensitive to CDK1 and PP2A balance.
    El Dika M; Dudka D; Prigent C; Tassan JP; Kloc M; Kubiak JZ
    Int J Dev Biol; 2014; 58(10-12):767-74. PubMed ID: 26154318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective chemical inhibition as a tool to study Cdk1 and Cdk2 functions in the cell cycle.
    Krasinska L; Cot E; Fisher D
    Cell Cycle; 2008 Jun; 7(12):1702-8. PubMed ID: 18583935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells.
    Xiao D; Johnson CS; Trump DL; Singh SV
    Mol Cancer Ther; 2004 May; 3(5):567-75. PubMed ID: 15141014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual Cdk1/2 activity after DNA damage promotes senescence.
    Müllers E; Silva Cascales H; Burdova K; Macurek L; Lindqvist A
    Aging Cell; 2017 Jun; 16(3):575-584. PubMed ID: 28345297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grapes(Chk1) prevents nuclear CDK1 activation by delaying cyclin B nuclear accumulation.
    Royou A; McCusker D; Kellogg DR; Sullivan W
    J Cell Biol; 2008 Oct; 183(1):63-75. PubMed ID: 18824564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.